Related references
Note: Only part of the references are listed.Rabbit Anti-T Cell Globulin in Allogeneic Hematopoietic Cell Transplantation
Jan Storek et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Impact of ATG-containing reduced-intensity conditioning after single- or double-unit allogeneic cord blood transplantation
Laurent Pascal et al.
BLOOD (2015)
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience
R. Nelson et al.
BONE MARROW TRANSPLANTATION (2015)
Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis
Rick Admiraal et al.
LANCET HAEMATOLOGY (2015)
Haploidentical hematopoietic SCT may be superior to conventional consolidation/maintenance chemotherapy as post-remission therapy for high-risk adult ALL
Y-Q Sun et al.
BONE MARROW TRANSPLANTATION (2015)
Population Pharmacokinetic Modeling of Thymoglobulin (R) in Children Receiving Allogeneic-Hematopoietic Cell Transplantation: Towards Improved Survival Through Individualized Dosing
Rick Admiraal et al.
CLINICAL PHARMACOKINETICS (2015)
Induction of suppressive allogeneic regulatory T cells via rabbit antithymocyte polyclonal globulin during homeostatic proliferation in rat kidney transplantation
Rafael Valdez-Ortiz et al.
TRANSPLANT INTERNATIONAL (2015)
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor
Raynier Devillier et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
Taiga Nishihori et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
High Serum Level of Antithymocyte Globulin Immediately before Graft Infusion Is Associated with a Low Likelihood of Chronic, But Not Acute, Graft-versus-Host Disease
Sumit Chawla et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Conditioning Chemotherapy Dose Adjustment in Obese Patients: A Review and Position Statement by the American Society for Blood and Marrow Transplantation Practice Guideline Committee
Joseph Bubalo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Effect of Antithymocyte Globulin Source on Outcomes of Bone Marrow Transplantation for Severe Aplastic Anemia
Joseph H. Antin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Tacrolimus/sirolimus vs tacrolimus/methotrexate as GVHD prophylaxis after matched, related donor allogeneic HCT
Corey Cutler et al.
BLOOD (2014)
T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT
Yi Luo et al.
BLOOD (2014)
Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial
Y. Wang et al.
BONE MARROW TRANSPLANTATION (2014)
Effective prevention of GVHD using in vivo T-cell depletion with anti-lymphocyte globulin in HLA-identical or -mismatched sibling peripheral blood stem cell transplantation
C. Wolschke et al.
BONE MARROW TRANSPLANTATION (2014)
Unmanipulated haploidentical BMT following non-myeloablative conditioning and post-transplantation CY for advanced Hodgkin's lymphoma
A. Raiola et al.
BONE MARROW TRANSPLANTATION (2014)
Favorable impact of pre-transplant ATG on outcomes of reduced-intensity hematopoietic cell transplants from partially mismatched unrelated donors
A. A. Langston et al.
BONE MARROW TRANSPLANTATION (2014)
Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice
T. Ruutu et al.
BONE MARROW TRANSPLANTATION (2014)
Comparing i.v. BU dose intensity between two regimens (FB2 vs FB4) for allogeneic HCT for AML in CR1: a report from the Acute Leukemia Working Party of EBMT
M. A. Kharfan-Dabaja et al.
BONE MARROW TRANSPLANTATION (2014)
New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin®) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
Mohamad Mohty et al.
DRUGS (2014)
Diagnostic and Therapeutic Advances in Blastic Plasmacytoid Dendritic Cell Neoplasm: A Focus on Hematopoietic Cell Transplantation
Mohamed A. Kharfan-Dabaja et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
A phase II study of sirolimus, tacrolimus and rabbit anti-thymocyte globulin as GVHD prophylaxis after unrelated-donor PBSC transplant
S. K. Khaled et al.
BONE MARROW TRANSPLANTATION (2013)
Reduced intensity conditioning is effective for hematopoietic SCT in dyskeratosis congenita-related BM failure
M. Ayas et al.
BONE MARROW TRANSPLANTATION (2013)
Anti-Thymocyte Globulin (Thymoglobulin), Tacrolimus, and Sirolimus as Acute Graft-versus-Host Disease Prophylaxis for Unrelated Hematopoietic Stem Cell Transplantation
Zaid Al-Kadhimi et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Quality of Life of Patients after Allogeneic Hematopoietic Stem Cell Transplantation with Antihuman Thymocyte Globulin
Zheng-Ping Yu et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
Haploidentical Transplantation Using T Cell Replete Peripheral Blood Stem Cells and Myeloablative Conditioning in Patients with High-Risk Hematologic Malignancies Who Lack Conventional Donors is Well Tolerated and Produces Excellent Relapse-Free Survival: Results of a Prospective Phase II Trial
Scott R. Solomon et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
First- and Second-Line Systemic Treatment of Acute Graft-versus-Host Disease: Recommendations of the American Society of Blood and Marrow Transplantation
Paul J. Martin et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2012)
IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD
C. M. Jol-van der Zijde et al.
BONE MARROW TRANSPLANTATION (2012)
Intensification of GVHD prophylaxis with low-dose ATG-F before allogeneic PBSC transplantation from HLA-identical siblings in adult patients with hematological malignancies: results from a retrospective analysis
F. Bonifazi et al.
BONE MARROW TRANSPLANTATION (2012)
Comparing efficacy of reduced-toxicity allogeneic hematopoietic cell transplantation with conventional chemo-(immuno) therapy in patients with relapsed or refractory CLL: a Markov decision analysis
M. A. Kharfan-Dabaja et al.
BONE MARROW TRANSPLANTATION (2012)
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
Joseph Pidala et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Anti-T Lymphocyte Globulin (ATG) Induces Generation of Regulatory T Cells, at Least Part of Them Express Activated CD44
Orly Shimony et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2012)
Antithymocyte globulin for acute-graft-versus-host-disease prophylaxis in patients undergoing allogeneic hematopoietic cell transplantation: a systematic review
A. Kumar et al.
LEUKEMIA (2012)
Assessment of Batch to Batch Variation in Polyclonal Antithymocyte Globulin Preparations
Irene Popow et al.
TRANSPLANTATION (2012)
ATG Prevents Severe Acute Graft-versus-Host Disease in Mismatched Unrelated Donor Hematopoietic Cell Transplantation
Joseph Pidala et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Alternative donor transplantation after reduced intensity conditioning: results of parallel phase 2 trials using partially HLA-mismatched related bone marrow or unrelated double umbilical cord blood grafts
Claudio G. Brunstein et al.
BLOOD (2011)
Chronic graft-versus-host disease: long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius
Gerard Socie et al.
BLOOD (2011)
Advances in umbilical cord transplantation: the role of thymoglobulin/ATG in cord blood transplantation
Mohamad Mohty et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Monitoring and Preemptive Rituximab Therapy for Epstein-Barr Virus Reactivation after Antithymocyte Globulin Containing Nonmyeloablative Conditioning for Umbilical Cord Blood Transplantation
Anne H. Blaes et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Cord Blood Transplantation from Unrelated Donors in Adults with High-Risk Acute Myeloid Leukemia
Jaime Sanz et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
High Rabbit-Antihuman Thymocyte Globulin Levels Are Associated with Low Likelihood of Graft-vs-Host Disease and High Likelihood of Posttransplant Lymphoproliferative Disorder
Peter J. Podgorny et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Pre-emptive treatment of acute GVHD: a randomized multicenter trial of rabbit anti-thymocyte globulin, given on day+7 after alternative donor transplants
A. Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2010)
Low Serum Levels of Total Rabbit-IgG Is Associated with Acute Graft-Versus-Host Disease after Unrelated Donor Hematopoietic Stem Cell Transplantation: Results from a Prospective Study
Mats Remberger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
Improved Nonrelapse Mortality and Infection Rate with Lower Dose of Antithymocyte Globulin in Patients Undergoing Reduced-Intensity Conditioning Allogeneic Transplantation for Hematologic Malignancies
Mehdi Hamadani et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
HLA-Mismatched Unrelated Donors as an Alternative Graft Source for Allogeneic Stem Cell Transplantation after Antithymocyte Globulin-Containing Conditioning Regimen
Nicolaus Kroeger et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2009)
TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors
Holbrook E. Kohrt et al.
BLOOD (2009)
Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial
Juergen Finke et al.
LANCET ONCOLOGY (2009)
HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide
Leo Luznik et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Comparison of Outcomes of HLA-Matched Related, Unrelated, or HLA-Haploidentical Related Hematopoietic Cell Transplantation following Nonmyeloablative Conditioning for Relapsed or Refractory Hodgkin Lymphoma
Lauri M. Burroughs et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors
Francis Ayuk et al.
EXPERIMENTAL HEMATOLOGY (2008)
Mechanisms of action of antithymocyte globulin: T-cell depletion and beyond
M. Mohty
LEUKEMIA (2007)
Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens
Richard E. Champlin et al.
BLOOD (2007)
Antithymocyte globulins suppress dendritic cell function by multiple mechanisms
Cord Naujokat et al.
TRANSPLANTATION (2007)
Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation
Claudio G. Brunstein et al.
BLOOD (2006)
Conditioning including antithymocyte globulin followed by unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA-identical sibling transplantation
DP Lu et al.
BLOOD (2006)
Antithymocyte globulin pharmacokinetics in pediatric patients after hematopoietic stem cell transplantation
MG Seidel et al.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2005)
Protective conditioning for acute graft-versus-host disease
R Lowsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Heterogeneous clearance of antithymocyte globulin after CD34+-selected allogeneic hematopoietic progenitor cell transplantation
I Kakhniashvili et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Polyclonal rabbit antithymocyte globulin triggers B-Cell and plasma cell apoptosis by multiple pathways
MS Zand et al.
TRANSPLANTATION (2005)
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse
F Aversa et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Antithymocyte globulin induces ex vivo and in vivo depletion of myeloid and plasmacytoid dendritic cells
LB Fang et al.
TRANSPLANTATION (2005)
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects
A Bacigalupo
BONE MARROW TRANSPLANTATION (2005)
Graft-versus-host disease following allogeneic transplantation from HLA-identical sibling with antithymocyte globulin-based reduced-intensity preparative regimen
M Mohty et al.
BLOOD (2003)
Pharmacokinetics and pharmacodynamics of anti-thymocyte globulin in recipients of partially HLA-matched blood hematopoietic progenitor cell transplantation
EK Waller et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin
J Finke et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide
PV O'Donnell et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2002)
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)
A Bacigalupo et al.
BONE MARROW TRANSPLANTATION (2001)
Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO)
A Bacigalupo et al.
BLOOD (2001)
Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell-depleted SCT
JWJ van Esser et al.
BLOOD (2001)
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin
M Remberger et al.
CLINICAL TRANSPLANTATION (2001)
Graft-versus-host disease - Treatment of steroid-resistant acute graft-versus-host disease with anti-thymocyte globulin
H Khoury et al.
BONE MARROW TRANSPLANTATION (2001)
Mechanisms involved in antithymocyte globulin immuno suppressive activity in a nonhuman primate model
X Préville et al.
TRANSPLANTATION (2001)
A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease
L Cragg et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2000)
Share Paper
